J. Safra Asset Management’s BioNTech BNTX Stock Holding History

J. Safra Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-77	Closed	-$6.84K	–	644
2026 Q1	$6.84K	Buy	77 +52	+208%	+$5.34K	﹤0.01%	415
2025 Q4	$2.38K	Hold	25	–	–	﹤0.01%	538
2025 Q3	$2.47K	Hold	25	–	–	﹤0.01%	373
2025 Q2	$2.66K	Buy	+25	New	+$2.52K	﹤0.01%	338
2024 Q4	–	Sell	-3	Closed	-$355	–	347
2024 Q3	$355	Buy	+3	New	+$276	﹤0.01%	293

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

J. Safra Asset Management's BNTX Position: Q2 2026 in Review

J. Safra Asset Management sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 77 shares — an estimated $6.84K sold.

J. Safra Asset Management first reported a position in BNTX in Q3 2024 and held it in 5 quarters. The position peaked at $6.84K in Q1 2026. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

J. Safra Asset Management reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
J. Safra Asset Management sold 77 BioNTech shares in Q2 2026, an estimated $6.84K.
J. Safra Asset Management first reported a position in BioNTech in Q3 2024 and held it in 5 quarters.
J. Safra Asset Management's BioNTech position peaked at $6.84K in Q1 2026.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.